- cross-posted to:
- publichealth@mander.xyz
- cross-posted to:
- publichealth@mander.xyz
Pharma manufacturer Gilead making available at cost (2 million doses in most needed countries) while generics are developed and can later be distributed. Decent play from a Pharma company.
Sometimes “passive vaccine” is used to describe an injection of antibodies to directly fight an ongoing disease.